Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GPR35 | Q9HC97 | 2/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.50 |
| ▸ | TSHR | P16473 | 5/20 | 0.50 |
| ▸ | TP53 | P04637 | 1/20 | 0.50 |
| ▸ | HPGD | P15428 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.50 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.50 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.50 |
| ▸ | VCAM1 | P19320 | 1/20 | 0.49 |
| ▸ | TXNRD1 | Q16881 | 1/20 | 0.48 |
| ▸ | TXNRD3 | Q86VQ6 | 1/20 | 0.48 |
| ▸ | TXNRD2 | Q9NNW7 | 1/20 | 0.48 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.44 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.44 |
| ▸ | ACHE | P22303 | 2/20 | 0.43 |
| ▸ | PTPRC | P08575 | 1/20 | 0.42 |
| ▸ | S100A4 | P26447 | 1/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1795352 | 0.84 | TDP1 (0.57) | GPR35TDP1ALDH1A1TSHRTP53 | |
| SCHEMBL5962192 | 0.83 | VCAM1 (0.52) | GPR35TDP1ALDH1A1TSHRTP53 | |
| SCHEMBL698847 | 0.82 | VCAM1 (0.66) | GPR35TDP1ALDH1A1TSHRTP53 | |
| SCHEMBL11673788 | 0.80 | TSHR (0.44) | GPR35TDP1ALDH1A1TSHRMAPK1 | |
| SCHEMBL28857833 | 0.80 | TDP1 (0.57) | TDP1ALDH1A1TSHRVCAM1LMNA | |
| SCHEMBL2354315 | 0.80 | TSHR (0.64) | GPR35TDP1ALDH1A1TSHRSMN1; SMN2 | |
| SCHEMBL28760315 | 0.80 | VCAM1 (0.49) | GPR35TDP1ALDH1A1TSHRTP53 | |
| SCHEMBL16570514 | 0.78 | TDP1 (0.60) | TDP1ALDH1A1TSHRMAPK1LMNA | |
| SCHEMBL9053950 | 0.78 | TSHR (0.42) | GPR35TDP1ALDH1A1TSHRHPGD | |
| SCHEMBL8761094 | 0.78 | MAPK1 (0.60) | TDP1ALDH1A1TSHRMAPK1VCAM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2024101298-A1 | METHOD FOR PRODUCING MACROLIDE COMPOUND | エーザイ・アール・アンド・ディー・マネジメント株式会社 | 2024-05-16 | — | — | WO | disclosed |
| EP-2796455-A1 | METHOD FOR PRODUCING SULFONATE | Sumitomo Chemical Co., Ltd (JP) | 2014-10-29 | — | — | EP | disclosed |
| CN-104011039-A | Process for producing sulfonate | SUMITOMO CHEMICAL CO | 2014-08-27 | — | — | CN | disclosed |
| EP-1889826-B1 | METHOD FOR PRODUCING A HEXAHYDROFUROFURANOL DERIVATIVE | SUMITOMO CHEMICAL CO (JP) | 2011-10-26 | — | — | EP | disclosed |
| US-7951977-B2 | Process for producing hexahydrofurofuranol derivative | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2011-05-31 | — | — | US | disclosed |
| US-20090176999-A1 | Process for producing hexahydrofurofuranol derivative | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2009-07-09 | — | — | US | disclosed |
| EP-1889826-A1 | METHOD FOR PRODUCING HEXAHYDROFUROFURANOL DERIVATIVE | Sumitomo Chemical Company, Limited (JP) | 2008-02-20 | — | — | EP | disclosed |
| EP-0730869-B1 | BIODEGRADABLE MEDICINAL POLYMER ASSEMBLY WITH SUPERMOLECULAR STRUCTURE | YUI NOBUHIKO (JP) | 2001-06-27 | — | — | EP | disclosed |
| US-5855900-A | Supramolecular-structured biodegradable polymeric assembly for drug delivery | JAPAN ADVANCED INSTITUTE OF SCIENCE AND TECHNOLOGY (JP) | 1999-01-05 | — | — | US | disclosed |
| EP-0730869-A1 | BIODEGRADABLE MEDICINAL POLYMER ASSEMBLY WITH SUPERMOLECULAR STRUCTURE | Yui, Nobuhiko (JP) | 1996-09-11 | — | — | EP | disclosed |
| US-4212811-A | Bicyclic lactone intermediates | THE UPJOHN COMPANY (US) | 1980-07-15 | — | — | US | disclosed |
| US-3954833-A | PROSTAGLANDINS | THE UPJOHN COMPANY (US) | 1976-05-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090176999-A1 | Process for producing hexahydrofurofuranol derivative | DHFR, DHPS, CYP4B1 | GPR35 3863/4885TDP1 3181/4885ALDH1A1 349/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.